Sandra Levy
ARTICLES BY THIS AUTHOR
- 5/5/2020
CVS Health's Q1 driven by solid sales gains
CVS Health’s retail/long-term-care segment saw revenues of $22.7 billion for the quarter, driven partially by an 8% uptick in front-store sales and an 8.2% increase in prescription fills. - 5/5/2020
NACDS' Anderson among ASAE's 2020 fellows
The American Society of Association Executives is recognizing five outstanding association executives for its 2020 Class of Fellows. - 5/5/2020
Dr. Reddy's debuts generic DDAVP
The DDAVP (desmopressin acetate) injection brand and generic had a market value of approximately $20.9 million for the most recent 12 months ended March 2020, according to IQVIA. - 5/5/2020
AllianceRx Walgreens Prime renews CE sponsorship for NASP members
New CE courses for NASP members include modules on the human immunodeficiency virus, pulmonary arterial hypertension, and influenza. - 5/5/2020
Dr. Reddy's gets FDA blessing for Elyxby
Dr. Reddy's Elyxyb will provide treatment for adults with acute migraine with or without aura. - 5/5/2020
AbbVie's acquisition of Allergan approved by High Court of Ireland
The High Court of Ireland has approved the acquisition of Allergan by AbbVie by means of a scheme of arrangement that is expected to take place May 8. - 5/4/2020
Hy-Vee limits meat purchases amid work shortages in plants
Hy-Vee is allowing purchases of four packages of a combination of fresh beef, ground beef, pork and chicken. - 5/4/2020
PTCB offers online testing for the 1st time
Online test delivery now is available for all Pharmacy Technician Certification Board exams. - 5/3/2020
Teva, Celltrion introduce Rituxan biosimilar
Teva and Celltrion's Truxima is the only biosimilar to Rituxan. - 5/3/2020
Zydus gets tentative nod for generic Synjardy
Zydus Cadila’s generic Synjardy was given tentative approval for four dosage strengths.
